Flatiron Health today announced its presence at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition happening from December 6-9, 2025, in Orlando, Florida. Flatiron's ...

CR or mCR in 86% of patients within the first 12 months - Venetoclax-resistant secondary AML transformed from CMML responds to lenzilumab BURLINGAME, CA / ACCESS Newswire / November 4, 2025 / Taran ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Secura Bio, Inc. ( an integrated pharmaceutical company maximizing commercial outcomes for oncology medicines, today announced a poster presentation highlighting extended follow up analyses examining ...

NEW YORK, Nov. 3, 2025 /PRNewswire/ -- Canopy, the leader in Enterprise AI for oncology, today announced a partnership with Willamette Valley Cancer Institute and Research Center (WVCI), a leader in ...

Session Name: 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Precision targeting in MPN Session Date and Time: December 6, 2025; 9:30 AM – 11:00 AM ...

NORTON, Va. (WJHL) — In a Hematology/Oncology practice, every day brings challenges and heart. November’s Nurse Of The Month, ...

Standardized evaluation protocol improved transfer, ECSL outcomes, and re-transfer to discharge for pediatric hematologic oncology patients.

Panelists discussed these questions during a recent Institute for Value-Based Medicine® event held in Nashville, Tennessee, ...

Patients can now receive services at the University of Michigan Health-West’s new Hematology and Cancer Care building in ...

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have published a ...